66.9 F
Laguna Hills
Thursday, Sep 29, 2022
-Advertisement-

Immunis Lands Diamandis for Advisory Board

World leader: “I haven’t been this excited about a biotech company in a long time!”

Irvine-based Immunis Inc., an Irvine-based biotechnology company working on immunity problems caused by aging, has caught the attention of Peter H. Diamandis, who has jointed its executive advisory board.

Diamandis, who has created more than 25 companies in the areas of space, education, venture capital and longevity, was once named by Fortune magazine as one of the “World’s 50 Greatest Leaders.”

“I haven’t been this excited about a biotech company in a long time!” Diamandis said in a statement released by Immunis. “The approach Immunis is taking to reproduce the stem cell secretome and the focus on Sarcopenia is brilliant. Besides the multitude of potential longevity related benefits, battling Sarcopenia could have one of the biggest impacts on healthy aging we’ve seen this decade.”

Immunis was founded by Hans Keirstead, who was awarded a Business Journal Innovator of the Year earlier this month. For more on Keirstead, see this week’s issue of the Business Journal.

 

Peter J. Brennan
Peter J. Brennan
Peter J. Brennan has been a journalist for 40 years. He spent a decade in Latin America covering wars, narcotic traffickers, earthquakes, and business. His resume includes 15 years at Bloomberg News where his headlines and articles sometimes moved the market caps of companies he covered by hundreds of millions of dollars. His articles have been published worldwide, including the New York Times and the Washington Post; he's appeared on CNN, CBC, BBC, and Bloomberg TV. He was awarded a Kiplinger Fellowship at The Ohio State University.
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-